Nilotinib Hcl
Brand name: Tasigna
Rank #155 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$100.9M
Total Cost
6,308
Total Claims
$100.9M
Total Cost
393
Prescribers
$16K
Cost per Claim
11
Beneficiaries
6,373
30-Day Fills
$257K
Avg Cost/Provider
16
Avg Claims/Provider
Share of Medicare Part D Spending
0.04%
of total Medicare Part D spending
$100.9M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $100.9M total
🔎 Data Overview
At $16,003 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $256,861 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $9,176,960 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Nilotinib Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Wahid Hanna | Hematology-Oncology | Knoxville, TN | 89 | $1.3M |
| 2 | Michael Moffett | Hematology-Oncology | Clovis, CA | 48 | $916K |
| 3 | Paul Brager | Hematology-Oncology | Bridgport, WV | 42 | $835K |
| 4 | Samir Alsawah | Hematology-Oncology | Port Huron, MI | 47 | $762K |
| 5 | Samuel Bailey | Hematology-Oncology | Hazard, KY | 37 | $748K |
| 6 | Bradley Lair | Hematology-Oncology | Des Moines, IA | 35 | $700K |
| 7 | Joseph Jones | Hematology-Oncology | Daphne, AL | 38 | $680K |
| 8 | Heather Fox | Physician Assistant | Ann Arbor, MI | 44 | $641K |
| 9 | Roberto Cano | Internal Medicine | Hollywood, FL | 31 | $617K |
| 10 | Elizabeth Cull | Hematology-Oncology | Greenville, SC | 35 | $604K |
| 11 | Aleda Toma | Hematology-Oncology | Oklahoma City, OK | 36 | $593K |
| 12 | Jeffrey Yorio | Hematology-Oncology | Austin, TX | 31 | $591K |
| 13 | William Kellogg | Hematology-Oncology | Sumter, SC | 35 | $584K |
| 14 | Ravitharan Krishnadasan | Hematology-Oncology | Tucson, AZ | 40 | $584K |
| 15 | Manuel Gonzalez | Hematology-Oncology | Sumter, SC | 28 | $573K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 152 | Relugolix (Orgovyx) | $107.3M | 38,821 |
| 153 | Pen Needle, Diabetic (Ultra-Fine Mini Pen Needle) | $105.0M | 1,305,150 |
| 154 | Divalproex Sodium (Divalproex Sodium) | $103.4M | 1,921,840 |
| 155 | Nilotinib Hcl (Tasigna) | $100.9M | 6,308 |
| 156 | Quetiapine Fumarate (Quetiapine Fumarate) | $100.9M | 3,820,737 |
| 157 | Ubrogepant (Ubrelvy) | $100.6M | 75,781 |
| 158 | Darunavir/Cobicistat (Prezcobix) | $99.7M | 38,374 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology